Morning Brief — Tuesday, August 18, 2026

Market Overview

Markets are under mild pressure this morning as Treasury yields jump and oil surges toward $91/barrel (Brent) after Iran ruled out extending its MOU with the United States, injecting fresh geopolitical risk into an already cautious tape. SPY futures are down ~0.4% pre-bell, with tech names like Nvidia, Micron, and SanDisk all pulling back despite yesterday’s S&P 500 record close. The session will be bifurcated: energy and defense-adjacent names riding the oil spike higher while rate-sensitive growth and big tech absorb the yield headwind.

Claude’s Call

DOWN — The combination of a 10-year yield spike and genuine Middle East escalation risk (Iran walking away from negotiations, Strait of Hormuz traffic down 33%) creates a meaningful headwind for the growth-heavy S&P 500 today; with the index coming off a record high and sentiment already stretched, this is a sell-the-rip session where energy outperforms but the broad market gives back 0.5–1.0%.

Top Movers

ETON (+44.3%) — $58.86 → $75.26 (+27.8% upside) Thesis: This is the real deal — ETON smashed Q2 estimates with $37.6M in revenue (implying ~99% YoY growth), flipped to profitability, and raised FY2026 guidance from >$120M to >$145M (~21% raise). At least one analyst has publicly called the new guidance conservative, which is the kind of fuel that keeps post-earnings momentum alive for 5–10 days. Technically, ETON is at its all-time high with the 50d SMA ($38.52) so far below it’s almost irrelevant — this is a momentum stock on a new trajectory, not a mean-reversion trade. Levels: Exit at Fib 1.272 extension of $75.26 — the next logical resistance in open air. Support at Fib 23.6% retracement of $51.87; a break of $45.15 (38.2%) would signal the move is unwinding fast.

AMLX (+35.8%) — $29.36 → $35.04 (+19.3% upside) Thesis: Avexitide just delivered a clean Phase 3 win — hitting both primary and secondary endpoints in bariatric hypoglycemia, a condition with no approved therapy. This is genuine binary-event alpha: the drug was acquired cheap in a bankruptcy auction, and a successful late-stage readout fundamentally revalues the pipeline. The 2.63x volume ratio is the highest confirmation signal on today’s entire list — real buyers, not just a sympathy squeeze. Trading at a 3-year high with the 50d SMA at $18.47, meaning fresh institutional buyers have no overhead baggage from older longs. Levels: Exit at Fib 1.272 extension of $35.04, then $41.10 for longer-term holders. Support at $26.13 (23.6% retrace) — hold above that and the breakout structure is intact.

TRGP (+7.9%) — $297.49 → $314.42 (+5.7% upside) Thesis: Targa Resources reported record Q2 earnings with revenue up to $4.44B (vs $4.26B prior year), hiked the dividend 25%, and raised full-year guidance — all while buying back stock. This is a fundamentals-driven move, not a geopolitical sympathy trade, though today’s oil spike adds a tailwind. The stock is hitting a 6-month high and breaking out above prior consolidation, with the 50d SMA ($268.54) well below providing a clean runway. Midstream infrastructure is structurally cheap vs. upstream at this point in the cycle. Levels: Exit at Fib 1.272 extension of $314.42. Near-term support at $277.51 (23.6% retrace); deeper support at $266.90 (38.2%).

AEHR (+8.7%) — $134.06 → $167.45 (+24.9% upside) Thesis: A $22M follow-on production order from a major AI processor customer is exactly the kind of concrete, revenue-converting news that sustains semiconductor momentum — this isn’t a concept stock anymore, it’s booking real AI-driven WLP burn-in revenue. Up 500%+ YTD with a fresh Wall Street initiation calling the PT conservative. That said, the stock has run hard from its 6-month low of $29 and is extended; treat this as a high-conviction but risk-managed position. The CEO selling $5.2M of stock (10% of holdings) after a 564% rally is a flag worth acknowledging — don’t ignore it. Levels: Exit at Fib 1.272 extension of $167.45. Support at $112.16 (23.6% retrace) — a full 16% below current price, so size accordingly.

HAE (+15.5%) — $104.85 → $118.75 (+13.3% upside) Thesis: Haemonetics beat both revenue ($339M) and adjusted EPS in Q1 FY2027, raised fiscal year revenue guidance, and is executing across all three platforms (Plasma, Interventional, and Hospital). The 90-day return of 61% sounds rich, but a DCF analysis suggests the stock may still be 49% below intrinsic value — an unusual setup where momentum and value are aligned simultaneously. CEO Christopher Simon has been unusually specific and confident on the call, a positive management tone signal. At a fresh 6-month high, there’s no overhead resistance to fight through. Levels: Exit at Fib 1.272 extension of $118.75. Support at $92.19 (23.6% retrace) and $84.56 (38.2%).

LUNR (+8.3%) — $19.01 → $24.50 (+28.9% upside) Thesis: A $600M+ multi-satellite communications program authorization is a legitimate contract win — not a hope trade. Stifel upgraded to Buy post-announcement, citing nearly 50% upside. Revenue growth of 309% YoY means the fundamental story is inflecting fast. However, the stock sits well below its 6-month high of $45.70, so this is a recovery trade from beaten-down territory, not a parabolic chase. The 50d SMA at $18.30 just flipped to support, offering a clean technical entry right at the moving average. Levels: Exit at $24.50 (Fib 61.8% of the 6mo swing — first meaningful resistance in the retrace). Hard support at $18.30 (50d SMA); below $17 is a stop-out zone.

YPF (+6.4%) — $53.26 → $62.25 (+16.9% upside) Thesis: YPF posted record adjusted EBITDA of $2.8B in Q2, raised 2026 guidance, and is advancing the Argentina LNG project with Eni and XRG toward a 12 MTPA capacity target — a multi-year export growth story. Peter Thiel’s fund just disclosed a $76M stake in peer VIST, which has improved sentiment across Argentine energy names broadly. Vaca Muerta shale output is the real driver here — this isn’t a commodity price trade, it’s a production ramp story. Still 10% below its 6-month high of $56.35, with room to recover. Levels: Exit at $56.35 (prior 6-month high); beyond that, Fib 1.272 extension of $62.25. Support at $51.23 (23.6% retrace) and $49.84 (50d SMA).

SNDK (+7.4%) — $1,641.11 → $1,908.39 (watch — near Fib resistance) ⚠️ Caution flag: SNDK is up 35% on the week and 591% on the year. The Fib 38.2% retrace from its 6-month high sits at $1,644 — it’s currently testing this as support, but in a rising yield environment with tech selling off this morning per the headlines, this is a fragile setup. Jim Cramer just broke his own lifetime trading rule to buy this. That’s not a buy signal — that’s a contrarian sell signal. The WSB section will cover this in more detail. Levels: Immediate resistance at Fib 23.6% of $1,908. Support at $1,644 (38.2%) then $1,431 (50%). Chasing here is dangerous.

Headlines to Watch

Iran Rules Out Extending MOU with U.S. — Direct escalation risk for Strait of Hormuz (33% shipping drop already), supporting oil above $90/Brent; energy longs (TRGP, YPF, CRGY, SM, TALO) get a macro tailwind while tech/consumer takes the yield hit.
Klarna Plunges 24.65% on Lowered FY2026 Revenue Guidance — A major fintech IPO cutting guidance this early in its public life is a confidence-shaking moment for the BNPL/fintech sector; watch for contagion in Affirm (AFRM) and PayPal (PYPL) today.
Bank of America Raises Micron (MU) Price Target to $1,550, Projecting $200–250 EPS by 2030 — Validates the HBM/AI memory supercycle thesis; directly supports SanDisk’s structural story but note both are selling off this morning on yield spike — buy the dip if support holds on MU.
Berkshire Hathaway Made Alphabet Its Largest Q2 Purchase — Buffett buying GOOGL at scale is a meaningful signal that value investors see AI infrastructure buildout as durable; watch GOOGL and cloud peers for a sentiment lift if the yield spike moderates later today.
Retail Earnings Wave Complete: HD Beats, TGT/ROST/LOW Disappoint — Home Depot’s tariff refund comment is critical — it means import cost relief is flowing through margins; however, TGT and ROST missing/guiding cautiously suggests consumer bifurcation (home improvement OK, discretionary soft).
Aehr Test Systems CEO Sells $5.2M Stock (10% of Holdings) After 564% Rally — Insider selling after parabolic runs is a classic distribution signal; doesn’t mean the stock crashes immediately, but risk management demands tight stops for new buyers.
CoreWeave Bull Case at $105 — 36% Upside Claimed — With AI infrastructure capex remaining the dominant market theme and CoreWeave below recent highs, any confirmation of revenue acceleration would be a high-beta catalyst; worth watching as a leading indicator for hyperscaler sentiment.

Claude’s Top Picks

AMLX (+35.8% today, +29.5% week) — $29.36 → $35.04 (+19.3% upside) Valuation: Pre-profit biotech with negative forward P/E, but this is a pipeline-value situation — avexitide’s Phase 3 success creates a new asset worth multiples of current market cap if approved. Upside: Clean Phase 3 win on both endpoints in a market with no approved competitor; 2.63x volume ratio confirms institutional conviction, not just retail momentum. Risk: Post-trial euphoria fades fast if FDA filing timeline disappoints or if management raises capital at current elevated prices — watch for any shelf registration filing.

TRGP (+7.9% today, +11.8% week) — $297.49 → $314.42 (+5.7% upside) Valuation: Midstream MLPs trade on EV/EBITDA; at a 7x five-year run, fair value is debated, but record earnings + 25% dividend hike + buybacks = shareholder return story that is genuinely underrepresented in the current price. Upside: Iran escalation keeps oil elevated, which directly lifts NGL volumes and midstream throughput; guidance raise was concrete and the dividend hike signals management confidence in free cash flow durability. Risk: A rapid oil de-escalation (Strait of Hormuz reopening, ceasefire news) removes the geopolitical premium and could retrace 8–10% quickly; also near 6-month high so any macro risk-off would pressure the name.

HAE (+15.5% today, +21.1% week) — $104.85 → $118.75 (+13.3% upside) Valuation: Mixed signals per news — market multiples lean expensive, but DCF analysis suggests 49% discount to intrinsic value; the disconnect likely reflects the market undermodeling the Plasma growth cycle duration. Upside: Raised fiscal 2027 guidance with explicit call-outs of new product adoption (Persona PLUS, VASCADE MVP XL) driving utilization — these are high-margin consumable pulls, not one-time revenue. Risk: At a fresh all-time high with no overhead technical resistance, but that’s a double-edged sword — profit-taking could be sharp in a risk-off tape like today; the 23.6% Fib retrace at $92.19 is a long way down if sentiment shifts.

LUNR (+8.3% today, +15.9% week) — $19.01 → $24.50 (+28.9% upside) Valuation: Negative forward P/E (pre-profit), but 309.8% revenue growth means the EV/Revenue multiple is the right lens — and at sub-$1B market cap for a $600M+ contracted backlog company, this is structurally cheap. Upside: $600M multi-satellite contract + Stifel upgrade + 50d SMA now acting as support creates a technically and fundamentally aligned setup; space infrastructure is a multi-year secular theme, not a cycle. Risk: LUNR is still 57% below its 6-month high of $45.70 — there are trapped longs above who will sell into every rally; the stock has a history of violent reversals, and any NASA budget news (its primary customer) is a binary risk.

CRGY (+6.7% today, +6.6% week) — $12.89 → $14.91 (+15.7% upside) Valuation: Not in the comps table, but as a Permian-focused E&P with record free cash flow, tripled acquisition synergies, and a $0.12/share dividend (ex-date was yesterday), it screens cheap vs. Permian peers on EV/EBITDA. Upside: Geopolitical oil premium is the immediate tailwind, but the structural story is synergy realization — Permian cost cuts delivering ahead of schedule with guidance raised; this is operational execution, not just a commodity ride. Risk: Oil de-escalation is the primary risk; also small-cap E&P liquidity can be thin in a broader risk-off move — today’s vol_vs_avg of 0.03 is concerningly low, suggesting conviction buyers are limited.

Avoid

SNDK — Up 35% this week and 591% YTD, currently testing its own Fib 38.2% retrace as support ($1,644) while the broader tech tape is selling off on rising yields; the risk/reward for new buyers is deeply asymmetric to the downside, and with the CEO having likely locked in massive gains already, any macro wobble triggers a cascade.

ETON — The fundamental story is genuinely strong, but at +261% YTD and +44% in a single day, the stock is trading at its all-time high with zero volume conviction (vol_vs_avg of 0.17 — barely 1/5th of average daily volume on a 44% up day), which suggests the move was gap-up thin-market, not institution-backed buying; the Fib 23.6% retrace at $51.87 is nearly 12% below — anyone buying here is stacking up on top with no margin of safety.

AEHR — A great fundamental story (AI wafer burn-in demand is real) but the CEO just sold $5.2M of stock (10% of holdings) after a 564% rally, the 20d low is $65.40 (more than 50% below current price), and the nearest Fib support (23.6%) at $112.16 represents a 16% drawdown from here; insider distribution + extreme extension = respect the risk, don’t chase the momentum.

WSB Sentiment Check

SNDK — WSB says: BULLISH (80% bullish), 347 mentions, 928 upvotes Claude says: DISAGREE — The structural HBM/NAND thesis is sound, but the technicals are screaming caution right now: yields are spiking, tech is selling off in pre-market, and the stock is sitting directly on Fib 38.2% support ($1,644) after a 35% weekly run — that’s not a buy setup, that’s a “hope it holds” setup; Jim Cramer just bought it, which is historically a contrarian sell signal, and the 6-month high of $2,335 is the real target but you don’t chase 591% winners into a yield spike.

MU — WSB says: BULLISH (80% bullish), 256 mentions, 1,275 upvotes Claude says: PARTIALLY AGREE — The BofA $1,550 PT and $200–250 EPS by 2030 thesis is credible (HBM demand is structural), but MU is currently between its 50d SMA ($960) and 6-month high ($1,213) with yields pushing higher — the setup is “right thesis, wrong day”; wait for the yield spike to resolve or for MU to hold the $960 50d SMA on volume before adding, rather than chasing the pre-market enthusiasm.

META — WSB says: BULLISH (80% bullish), 151 mentions, 854 upvotes Claude says: DISAGREE — META at $552 is trading 20% below its 6-month high of $688 and below every meaningful Fib support level in the 6-month range (23.6% is at $649, which it’s already under); this is a technically broken chart for now, and in a rising yield environment, high-multiple growth names face incremental multiple compression — the AI monetization story is intact long-term but the chart says “falling knife” until it reclaims the 50d SMA at $595.

SPCX — WSB says: BULLISH (80% bullish), 138 mentions, 253 upvotes Claude says: PARTIALLY AGREE — SPCX (space sector ETF/thematic) gets indirect support from the LUNR $600M contract win and the broader space infrastructure narrative, but at $140.82 it’s already 33% below its 6-month high of $211 and below its key Fib 61.8% support at $147.66 — it’s in technical no-man’s land; the secular theme is real but the chart is broken and WSB’s 80% bullish reading here looks like bottom-fishing without a catalyst.

NKE — WSB says: BULLISH (80% bullish), 135 mentions, 3,471 upvotes (highest upvote count of the group) Claude says: DISAGREE — and this is the most dangerous WSB call on the board today — NKE at $39.40 is sitting exactly at its 6-month low, every single Fib support level is above the current price (23.6% at $58.65, the stock is far below it), meaning it has broken through all support and is in freefall; 3,471 upvotes on a falling-knife bottom-fishing play in a stock that’s down from $64.60 to $39.40 is WSB at its most dangerous — this is “it can’t go lower” logic, and it absolutely can; avoid until it reclaims $43 (50d SMA) on volume.

Earnings Scorecard

KLAR (Klarna) — REPORTED | Stock: -24.65% Klarna cut FY2026 revenue guidance — a brutal signal for a company that just IPO’d, telling new shareholders the initial targets were too ambitious; the reaction is justified and possibly still insufficient if the guidance cut reflects a structural deterioration in BNPL credit quality rather than just macro softness. Sell-the-rip — analyst target at $24.55 is actually below the pre-earnings price, confirming Street has turned cautious.

BIDU (Baidu) — REPORTED | Stock: -6.91% Q2 missed estimates despite AI Cloud growth, with core advertising continuing to deteriorate as Chinese internet monetization struggles; the -6.9% reaction is justified — the AI pivot story is real but it’s not offsetting the core business decline fast enough. Hold/avoid — at $166 analyst target, there’s modest upside but the risk/reward is unexciting until AI revenue becomes the majority of the business.

ZIM (ZIM Integrated Shipping) — REPORTED | Stock: +4.09% EPS of $0.82 with the Maersk peer also beating suggests container shipping rates remain elevated; the +4% reaction seems proportionate — this is a cyclically cheap name in a positive rate environment. Modest buy-the-dip if it pulls back, but watch for any Strait of Hormuz resolution which would immediately compress rates.

AS (Amer Sports) — REPORTED | Stock: +3.86% Beat Q2 and raised 2026 outlook — Arc’teryx momentum continues to be the standout driver, and the +3.9% reaction feels slightly underdone given the guidance raise magnitude. Buy-the-dip on any weakness; this is a premium athletic brand in a multi-year growth phase.

BABA (Alibaba) — REPORTED | Stock: +3.52% EPS of $6.52 is solid, and BABA continues to benefit from China AI infrastructure spending and e-commerce stabilization; the muted +3.5% reaction reflects ongoing geopolitical overhang. Hold — the analyst target of $189.92 implies significant upside, but China macro risk keeps institutional buyers cautious.

ROST (Ross Stores) — REPORTED | Stock: -3.29% EPS of $7.15 with a -3.3% reaction suggests a guidance miss or weak forward commentary — off-price retail should be benefiting from consumer trade-down, so a miss here is a yellow flag for the broader consumer. Avoid — if even the value/off-price retailers are struggling, it confirms consumer spending deterioration.

TGT (Target) — REPORTED | Stock: -1.29% EPS of $7.57 with modest decline — Target continues to struggle with discretionary traffic and ongoing boycott headwinds; -1.3% reaction is justified but not panicked. Hold — at $144 analyst target there’s likely better value in the sector.

LOW (Lowe’s) — REPORTED | Stock: -0.86% EPS of $11.83 with minimal reaction — Lowe’s is a “show me” story until housing turns; management commentary around tariff refunds (similar to HD) is incrementally positive but not enough to drive re-rating. Hold — improvement is gradual, not catalytic.

FN (Fabrinet) — REPORTED | Stock: +0.66% Record revenue and EPS, but margins and cash flow disappointed — classic case where top-line beat is undermined by cost structure concerns. The +0.7% reaction is appropriate; the margin question will define whether this breaks out or fades. Wait for margin confirmation next quarter before adding.

HD (Home Depot) — REPORTED | Stock: -0.64% Beat and maintained full-year outlook; the CFO’s tariff refund comment is structurally positive for margins. The -0.6% reaction is unjustified — this reads as sell-the-news on an otherwise clean print. Buy-the-dip at the 50d SMA ($~$355 area) if the broader market weakness creates a better entry.

WMT (Walmart) — REPORTED | Stock: -0.45% EPS of $2.81 with a flat reaction — Walmart is executing well and taking consumer share, but at current valuation levels there’s limited upside surprise available. Hold — a quality name that rarely disappoints but is already well-owned by institutions.

TJX (TJX Companies) — REPORTED | Stock: +0.29% EPS of $5.14 with a near-flat reaction despite the off-price tailwind that should be strongest in a cautious consumer environment; the muted reaction is puzzling. Hold — if off-price isn’t moving on consumer trade-down, it suggests the macro story is more complex than the bull thesis assumes.

Morning Brief prepared pre-market. All prices and levels based on data as of market open, August 18, 2026. Not financial advice.